News-Medical.netLudwig researchers extend potential for personalized immunotherapy to ovarian cancer, other tumorsNews-Medical.netA Ludwig Cancer Research study shows that ovarian cancer, which has proved resistant to currently available immunotherapie… Continue reading
City A.M.Rare disease firm Amryt reveals a "major" gene therapy tie-up as revenues riseCity A.M.Rare and orphan disease specialist Amryt Pharma has announced a major in-lincence agreement for a novel gene therapy platform as its revenues for … Continue reading
Oncology Nurse AdvisorAge Not a Deterrent to Immunotherapy for Malignant MelanomaOncology Nurse AdvisorPatients >65 years of age with metastatic melanoma who are treated with immunotherapy do not have an increased risk for immune-related adverse eve… Continue reading
Nasdaq |
Inovio’s (INO) Q4 Loss Narrower than Expected, Revenues Beat
Nasdaq Moreover, the company also received additional $1.2 million revenues under Inovio’s prior collaboration with Roche RHHBY for the development of Inovio’s DNA immunotherapy, INO-180. However, upside in revenues was partially offset by lower grants … |
|
Arbor Biotechnologies Discovers New CRISPR System Utilizing its Discovery Platform
GlobeNewswire (press release) CAMBRIDGE, Mass., March 15, 2018 (GLOBE NEWSWIRE) — Arbor Biotechnologies, an early stage life sciences company, today published its first findings of a new member of the CRISPR-Cas13 enzyme family—Cas13d, arising from Arbor’s discovery platform. In … |